WHO approves clinical trials on two new Ebola vaccines
The World Health Organisation has approved clinical trials for two new Ebola vaccines to combat an outbreak in Africa that has killed over 5,300 people. Read More: https://punchng.com/who-approves-clinical-trials-on-two-new-ebola-vaccines/
The World Health Organisation (WHO) has approved clinical trials for two new Ebola vaccines, as part of efforts to control an outbreak in Africa that has claimed over 5,300 lives. The vaccines, ChAdOx1 BDBV developed by the University of Oxford with the Serum Institute of India, and Moderna’s mRNA-1469, are designed specifically for the Bundibugyo virus.
The trial is being led by the National Institute for Biomedical Research in the Democratic Republic of Congo (DRC) with support from WHO and other partners. WHO chief Tedros Adhanom Ghebreyesus emphasized that while vaccines are powerful tools, they should be used in conjunction with proven measures such as early care, contact tracing, isolation, safe burials, and community engagement.
Brief written by urgent.news from Punch Nigeria's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
